US Stock MarketDetailed Quotes
CCM Concord Medical Services
- 0.590
- +0.086+17.13%
Close Apr 26 16:00 ET
25.62MMarket Cap-627P/E (TTM)
0.650High0.574Low9.39KVolume0.650Open0.504Pre Close5.90KTurnover0.07%Turnover RatioLossP/E (Static)43.42MShares1.60052wk High-0.09P/B8.27MFloat Cap0.38252wk Low--Dividend TTM14.01MShs Float7.391Historical High--Div YieldTTM15.18%Amplitude0.382Historical Low0.628Avg Price1Lot Size
Concord Medical Services Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -27.59%-276.47M | 39.69%-216.69M | -56.38%-359.31M | -6.09%-229.77M | -461.21%-216.58M | -244.36%-38.59M | 134.24%26.73M | 55.42%-78.08M | -135.71%-175.14M | 89.31%490.38M |
| Net income from continuing operations | 30.95%-531.02M | -47.13%-768.99M | -29.36%-522.67M | -14.75%-404.03M | -35.79%-352.09M | 9.24%-259.3M | -7.77%-285.68M | -234.37%-265.08M | -165.92%-79.28M | 31.88%120.27M |
| Operating gains losses | -246.71%-62.92M | 336.63%42.89M | -5,148.47%-18.12M | 101.41%359K | 60.23%-25.52M | -121.81%-64.17M | -559.94%-28.93M | 271.30%6.29M | 92.05%-3.67M | -223.27%-46.18M |
| Depreciation and amortization | -3.28%128.45M | 27.61%132.81M | 29.62%104.08M | 22.01%80.3M | 20.48%65.82M | -42.32%54.63M | -26.59%94.71M | -18.53%129.01M | -21.49%158.34M | 10.54%201.68M |
| Deferred tax | 81.85%-13.04M | -738.25%-71.85M | 184.34%11.26M | 40.57%-13.35M | -399.36%-22.46M | -40.94%7.5M | -42.56%12.7M | 5,219.21%22.12M | -101.85%-432K | 593.45%23.31M |
| Other non cash items | -44.07%192.35M | 260.10%343.93M | -8.51%95.51M | 14.52%104.39M | 97.17%91.16M | -63.10%46.23M | --125.29M | ---- | ---- | ---- |
| Change In working capital | -152.37%-55.01M | 325.40%105.03M | -42.87%-46.6M | 56.14%-32.62M | -150.37%-74.36M | 175.63%147.64M | 184.52%53.56M | 77.24%-63.38M | -244.28%-278.41M | 1,754.24%192.97M |
| -Change in receivables | 5,560.56%36.45M | 101.00%644K | -945.08%-64.45M | -272.55%-6.17M | -92.61%3.57M | 11.47%48.38M | 337.47%43.41M | -77.07%9.92M | 3,760.48%43.28M | 101.01%1.12M |
| -Change in inventory | 195.16%44.49M | -974.22%-46.75M | 69.87%-4.35M | -690.70%-14.45M | -201.33%-1.83M | 425.45%1.8M | 71.19%-554K | -710.48%-1.92M | 32.91%315K | 102.15%237K |
| -Change in prepaid assets | -15.05%-149.74M | -321.11%-130.16M | 62.53%-30.91M | -846.78%-82.5M | 211.86%11.05M | -134.86%-9.88M | 88.49%-4.21M | -347.88%-36.55M | 393.16%14.74M | -143.08%-5.03M |
| -Change in payables and accrued expense | -68.52%71.49M | -12.69%227.08M | 16,184.72%260.09M | 97.91%-1.62M | -245.95%-77.32M | 226.69%52.98M | 143.08%16.22M | -218.97%-37.64M | -78.80%31.64M | 20.65%149.26M |
| -Change in other current assets | 10,886.67%1.62M | 91.43%-15K | -144.64%-175K | -78.92%392K | -95.47%1.86M | 482.13%41.08M | -50.47%7.06M | 19.72%14.25M | -67.15%11.9M | 415.79%36.23M |
| -Change in other current liabilities | -518.30%-18.15M | 78.00%-2.94M | -4.02%-13.34M | -1.38%-12.82M | ---12.65M | --0 | --0 | ---- | ---- | ---- |
| -Change in other working capital | -172.03%-41.18M | 129.55%57.17M | -328.84%-193.46M | 8,771.25%84.54M | -92.82%953K | 258.78%13.27M | 26.91%-8.36M | 96.99%-11.43M | -3,511.85%-380.29M | 135.06%11.15M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -27.59%-276.47M | 39.69%-216.69M | -56.38%-359.31M | -17.62%-229.77M | -406.20%-195.35M | -244.36%-38.59M | 134.24%26.73M | 55.42%-78.08M | -135.71%-175.14M | 89.31%490.38M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 59.86%-47.68M | 79.01%-118.79M | -6.01%-565.98M | 50.17%-533.89M | -7.11%-1.07B | -219.59%-1B | -318.20%-313.01M | 80.86%-74.85M | -236.24%-391.08M | 314.96%287.06M |
| Net PPE purchase and sale | 69.48%-115.39M | 30.95%-378.14M | -8.56%-547.61M | 18.19%-504.43M | 3.90%-616.59M | -207.93%-641.6M | -96.50%-208.36M | 41.38%-106.04M | -120.42%-180.9M | 42.26%-82.07M |
| Net intangibles purchase and sale | -307.65%-4.21M | 94.76%-1.03M | -140.45%-19.71M | -1,323.26%-8.2M | -173.47%-576K | 110.52%784K | -87.05%-7.45M | ---3.99M | --0 | --0 |
| Net business purchase and sale | 2,704.35%59.9M | 96.52%-2.3M | -205.83%-66.03M | 112.02%62.39M | -56.82%-518.9M | -186.91%-330.89M | -394.22%-115.33M | 119.46%39.2M | -173.61%-201.41M | 6,708.89%273.61M |
| Net investment purchase and sale | --0 | -40.19%11.95M | 118.41%19.98M | -316.98%-108.49M | 200.00%50M | ---50M | --0 | 7.25%-121.5M | ---131M | --0 |
| Net other investing changes | ---- | 679.16%245.63M | 26.90%31.53M | 70.64%24.84M | 49.82%14.56M | -18.37%9.72M | -88.99%11.9M | 10.43%108.12M | 33.15%97.91M | 714.32%73.53M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 59.86%-47.68M | 79.01%-118.79M | -6.01%-565.98M | 50.17%-533.89M | -7.11%-1.07B | -219.59%-1B | -318.20%-313.01M | 80.86%-74.85M | -236.24%-391.08M | 314.96%287.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -32.74%257.65M | -40.37%383.09M | -43.56%642.45M | 121.78%1.14B | -57.34%513.27M | 533.52%1.2B | 261.04%189.9M | -119.97%-117.92M | 201.94%590.4M | -845.15%-579.14M |
| Net issuance payments of debt | -30.34%462.28M | 88.99%663.6M | -0.56%351.12M | -32.52%353.1M | 319.26%523.26M | -154.48%-238.64M | 194.35%438.02M | -174.61%-464.23M | 1,465.79%622.17M | -121.16%-45.55M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 655.54%109.57M | ---19.72M | --0 |
| Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---285.83M | --0 | ---453.56M |
| Net other financing activities | 27.05%-204.63M | -196.29%-280.51M | -62.90%291.33M | 7,957.49%785.2M | -100.69%-9.99M | 1,476.88%1.44B | -120.04%-104.71M | 4,435.95%522.57M | 84.94%-12.05M | 39.14%-80.03M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -32.74%257.65M | -40.37%383.09M | -43.56%642.45M | 121.78%1.14B | -57.34%513.27M | 533.52%1.2B | 261.04%189.9M | -119.97%-117.92M | 201.94%590.4M | -845.15%-579.14M |
| Net cash flow | ||||||||||
| Beginning cash position | 0.27%159.34M | -64.40%158.91M | 500.74%446.4M | -91.01%74.31M | 24.85%826.73M | -12.69%662.18M | -27.11%758.4M | 117.36%1.04B | 69.13%478.68M | 275.46%283.03M |
| Current changes in cash | -239.70%-66.5M | 116.83%47.6M | -175.50%-282.85M | 149.72%374.65M | -559.23%-753.59M | 270.26%164.1M | 64.42%-96.38M | -1,220.27%-270.85M | -87.81%24.18M | -2.42%198.29M |
| Effect of exchange rate changes | 94.86%-2.43M | -916.81%-47.17M | -81.00%-4.64M | -320.76%-2.56M | 152.94%1.16M | 192.36%459K | 101.40%157K | 35.47%-11.24M | -559.06%-17.42M | -159.58%-2.64M |
| End cash Position | -43.26%90.42M | 0.27%159.34M | -64.40%158.91M | 500.74%446.4M | -91.01%74.31M | 24.85%826.73M | -12.69%662.18M | 56.23%758.4M | 1.41%485.44M | 69.13%478.68M |
| Free cash flow | 34.10%-396.38M | 47.22%-601.5M | -53.45%-1.14B | 17.19%-742.67M | -11.44%-896.85M | -198.25%-804.77M | -34.88%-269.83M | 43.98%-200.05M | -193.85%-357.11M | 284.25%380.53M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg